Physician profile
Colin Failey
NPI 1992957922
$39,826.27
in general payments reported to CMS, 2019-2025
14 companies · $26K in 2025
The $26K reported for 2025 was more than what 98% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $398 · 2021: $111 · 2022: $432 · 2023: $4,088 · 2024: $8,700 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Food and Beverage: $2,778 · Honoraria: $2,400 · Travel and Lodging: $47.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,393.69 |
| Food and Beverage | $2,778.23 |
| Honoraria | $2,400.00 |
| Travel and Lodging | $47.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $21,354.32 | 2024-2025 | Daxxify |
| Abbvie INC. | $14,666.69 | 2023-2025 | |
| Rti Surgical, INC | $2,400.00 | 2024 | |
| Allergan, INC. | $568.10 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $292.64 | 2020 | |
| Sientra, INC. | $286.10 | 2019-2022 | |
| Motiva USA, LLC | $82.64 | 2025 | |
| Axogen | $57.48 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Mentor Worldwide LLC | $41.62 | 2022-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Biocircuit Technologies INC | $19.06 | 2025 | Nerve Tape |
| Tepha INC | $17.05 | 2019 | |
| Tela Bio, INC. | $14.67 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acelrx Pharmaceuticals, INC. | $13.50 | 2022 | |
| Kci USA, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Failey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.